The objective of this study was to investigate if Glycogen Synthase Kinase-3 β (GSK3β) contributes for of cAMP and WNT3a phosphorylation on activation and subsequent gene regulation involved in steroidogenesis in GC. To evaluate the interaction between WNT and cAMP/PKA pathways, GC cultures were treated with or without PI3K inhibitor LY294002 (LY) (30 μM, 30 min), and with or without Forskolin (FSK) (10 μM, 1.5 h) and followed by WNT3a (50 ng/mL, 30 min). Cells were collected and total protein was isolated in M-PER and quantified by BCA kit. Western blot were used to detect total and phosphorylated
The objective of this study was to investigate if Glycogen Synthase Kinase-3 β (GSK3β) contributes for of cAMP and WNT3a phosphorylation on activation and subsequent gene regulation involved in steroidogenesis in GC. To evaluate the interaction between WNT and cAMP/PKA pathways, GC cultures were treated with or without PI3K inhibitor LY294002 (LY) (30 μM, 30 min), and with or without Forskolin (FSK) (10 μM, 1.5 h) and followed by WNT3a (50 ng/mL, 30 min). Cells were collected and total protein was isolated in M-PER and quantified by BCA kit. Western blot were used to detect total and phosphorylated